Evidence map›Paper›PMID 39279542›Full record

ReviewAdvanced materials (Deerfield Beach, Fla.)2024

Quantitative in Vivo Molecular MRI.

Yingying Ning, Iris Yuwen Zhou, Peter Caravan

Abstract readReview
In one paragraph

Review in Advanced materials (Deerfield Beach, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yingying NingSpin-X Institute, School of Chemistry and Chemical Engineering, School of Biomedical Sciences and Engineering, State Key Laboratory of Luminescent Materials and Devices, Guangdong-Hong Kong-Macao Joint Laboratory of Optoelectronic and Magnetic Functional Materials, South China University of Technology, Guangzhou, 510641, China.ORCID 0000-0002-2942-2202
Iris Yuwen ZhouAthinoula A. Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA.ORCID 0000-0002-4351-7398
Peter CaravanAthinoula A. Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA.ORCID 0000-0002-3179-6537

Funding

Molecular MR Imaging of Hepatic FibrogenesisR01DK121789 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Peter D Caravan · 2019 to 2026
$5.0M
Molecular Imaging of Liver FibrosisR01DK104956 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI TANABE, KENNETH K · 2015 to 2019
$2.7M
Fibrogenesis Targeted Manganese Based MRI Contrast AgentR44DK134295 · NIDDK · REVEAL PHARMA · PI HOFFMAN, VERA · 2022 to 2024
$2.2M
Molecular Imaging of Renal FibrogenesisU01DK104302 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2014 to 2019
$2.1M
Quantitative MRI-PET Imaging of Pulmonary FibrosisK25HL148837 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ZHOU, IRIS YUWEN · 2020 to 2023
$686k
National Natural Science Foundation of China 22371077NHLBI NIH HHS HL1448837NHLBI NIH HHS K25 HL148837NIDDK NIH HHS DK104302NIDDK NIH HHS DK104956NIDDK NIH HHS DK121789NIDDK NIH HHS DK134295NIDDK NIH HHS R01 DK104956NIDDK NIH HHS R01 DK121789NIDDK NIH HHS R44 DK134295NIDDK NIH HHS U01 DK104302State Key Laboratory of Luminescent Materials and Devices Skllmd-2024-08
6 · The paper itself

Abstract

Molecular magnetic resonance imaging (MRI) combines chemistry, chemical biology, and imaging techniques to track molecular events non-invasively. Quantitative molecular MRI aims to provide meaningful, reproducible numerical measurements of molecular processes or biochemical targets within the body. In this review, the classifications of molecular MRI probes based on their signal-generating mechanism and functionality are first described. From there, the primary considerations for in vitro characterization and in vivo validation of molecular MRI probes, including how to avoid pitfalls and biases are discussed. Then, recommendations on imaging acquisition protocols and analysis methods to establish quantitative relationships between MRI signal change induced by the probes and the molecular processes of interest are provided. Finally, several representative case studies are highlighted that incorporate these features. Quantitative molecular MRI is a multidisciplinary research area incorporating expertise in chemical biology, inorganic chemistry, molecular probes, imaging physics, drug development, pathobiology, and medicine. The purpose of this review is to provide guidance to chemists developing MR imaging probes and methods in terms of in vitro and in vivo validation to accelerate the translation of these new quantitative tools for non-invasive imaging of biological processes.

Indexed as

Magnetic Resonance ImagingAnimalsContrast MediaHumansMolecular ProbesContrast MediaMolecular Probescontrast agentmolecular imagingmolecular probeMRIquantitative imaging

Identifiers

PMID39279542
PMCPMC11530320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.